Management of Cardiac Sarcoidosis With Mildly Impaired Cardiac Function
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Aitken M, Davidson M, Chan M, Urzua Fresno C, Vasquez L, Huo Y
. Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology. 2023; 307(2):e222483.
DOI: 10.1148/radiol.222483.
View
2.
Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S
. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2012; 15(3):347-54.
DOI: 10.1093/europace/eus316.
View
3.
Newman L, Rose C, Maier L
. Sarcoidosis. N Engl J Med. 1997; 336(17):1224-34.
DOI: 10.1056/NEJM199704243361706.
View
4.
Coleman G, Shaw P, Balfour Jr P, Gonzalez J, Kramer C, Patel A
. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2016; 10(4):411-420.
PMC: 5237422.
DOI: 10.1016/j.jcmg.2016.05.009.
View
5.
Futamatsu H, Suzuki J, Adachi S, Okada H, Otomo K, Ohara T
. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging. 2006; 22(3-4):443-8.
DOI: 10.1007/s10554-005-9043-x.
View